Theratechnologies Analyst Ratings
Theratechnologies Analyst Ratings
While ratings are subjective and will change, the latest Theratechnologies (THTX) rating was a reiterated with a price target of $0.00 to $9.00. The current price Theratechnologies (THTX) is trading at is $0.90, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/13/2023 | 900% | Cantor Fitzgerald | → $9 | Reiterates | Overweight → Overweight |
| 07/03/2023 | 122.22% | Canaccord Genuity | → $2 | Assumes | → Hold |
| 11/17/2022 | 900% | Cantor Fitzgerald | → $9 | Initiates Coverage On | → Overweight |
| 07/29/2021 | 233.33% | Canaccord Genuity | $8 → $3 | Downgrades | Buy → Hold |
| 04/19/2021 | 788.89% | Canaccord Genuity | $7 → $8 | Maintains | Buy |
| 04/15/2020 | 1122.22% | Canaccord Genuity | $12 → $11 | Maintains | Buy |
| 12/11/2019 | — | Mackie Research | Upgrades | Hold → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 07/13/2023 | 900% | 康托·菲茨杰拉德 | →$9 | 重申 | 超重→超重 |
| 07/03/2023 | 122.22% | 卡纳科特·格纳奇 | →$2 | 假设 | →保留 |
| 2022年11月17日 | 900% | 康托·菲茨杰拉德 | →$9 | 开始承保 | →超重 |
| 07/29/2021 | 233.33% | 卡纳科特·格纳奇 | $8→$3 | 评级下调 | 购买→Hold |
| 04/19/2021 | 788.89% | 卡纳科特·格纳奇 | $7→$8 | 维护 | 买 |
| 04/15/2020 | 1122.22% | 卡纳科特·格纳奇 | $12→$11 | 维护 | 买 |
| 2019年12月11日 | - | Mackie研究 | 升级 | 持有→购买 |
What is the target price for Theratechnologies (THTX)?
Therattech(THTX)的目标价是多少？
The latest price target for Theratechnologies (NASDAQ: THTX) was reported by Cantor Fitzgerald on July 13, 2023. The analyst firm set a price target for $9.00 expecting THTX to rise to within 12 months (a possible 900.00% upside). 3 analyst firms have reported ratings in the last year.
康托·菲茨杰拉德于2023年7月13日报道了Therattech(纳斯达克代码：THTX)的最新目标价。这家分析公司将目标价定为9美元，预计THTX将在12个月内上涨至(可能上涨900.00%)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Theratechnologies (THTX)?
最新分析师对热技术公司(THTX)的评级是多少？
The latest analyst rating for Theratechnologies (NASDAQ: THTX) was provided by Cantor Fitzgerald, and Theratechnologies reiterated their overweight rating.
纳斯达克(Sequoia Capital：THTX)的最新分析师评级由康托·菲茨杰拉德提供，Therattech重申其增持评级。
When is the next analyst rating going to be posted or updated for Theratechnologies (THTX)?
下一次发布或更新Therattech(THTX)分析师评级的时间是什么时候？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Theratechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Theratechnologies was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Therattech的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。TheratTechnology的上一次评级是在2023年7月13日提交的，所以你应该预计下一次评级将在2024年7月13日左右提供。
Is the Analyst Rating Theratechnologies (THTX) correct?
分析师对科技股(THTX)的评级正确吗？
While ratings are subjective and will change, the latest Theratechnologies (THTX) rating was a reiterated with a price target of $0.00 to $9.00. The current price Theratechnologies (THTX) is trading at is $0.90, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Therattech(THTX)评级被重申，目标价在0.00美元至9.00美元之间。THTX目前的交易价格为0.9美元，在分析师的预测范围内。